In vitro activity of colistin in antimicrobial combination against carbapenem-resistant acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam

Journal of Medical Microbiology

Volumn 64, Issue 10, 2015, Pages 1162-1169

  Le Minh, Vien ^a,b   Nhu, Nguyen Thi Khanh ^a,c   Phat, Voong Vinh ^a   Thompson, Corinne ^a,d   Lan, Nguyen Phu Huong ^a,e   Nga, Tran Vu Thieu ^a   Tam, Pham Thi Thanh ^a   Tuyen, Ha Thanh ^a   Nhu, Tran Do Hoang ^a   Van Hao, Nguyen ^e   Loan, Huynh Thi ^e   Yen, Lam Minh ^e   Parry, Christopher M ^a,d,f   Nghia, Ho Dang Trung ^a,e,g   Campbell, James I ^a,d   Hien, Tran Tinh ^a,d   Thwaites, Louise ^a,d   Thwaites, Guy ^a,d   Van Vinh Chau, Nguyen ^e   Baker, Stephen ^a,d,h  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^f LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^g Department of Biochemistry and Molecular Biology   (Viet Nam)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEFTRIAXONE; COLISTIN; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CONTROLLED STUDY; GENETIC ANALYSIS; GENOTYPE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MULTILOCUS VARIABLE NUMBER TANDEM REPEAT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRACHEAL ASPIRATION PROCEDURE; VENTILATOR ASSOCIATED PNEUMONIA; VIET NAM; ANTIBIOTIC RESISTANCE; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; DRUG POTENTIATION; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; PNEUMONIA, VENTILATOR-ASSOCIATED;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CLUSTER ANALYSIS; COLISTIN; DRUG SYNERGISM; GENOTYPE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PNEUMONIA, VENTILATOR-ASSOCIATED; VIETNAM;

EID: 84944720332     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000137     Document Type: Article

References (44)

1. Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R. & Bonomo, R. A. (2009). Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 53, 3628–3634.
2. Barnaud, G., Zihoune, N., Ricard, J. D., Hippeaux, M. C., Eveillard, M., Dreyfuss, D. & Branger, C. (2010). Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France. J Hosp Infect 76, 358–360.
3. Bergogne-Bérézin, E. & Towner, K. J. (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9, 148–165.
4. Choi, W. S., Kim, S. H., Jeon, E. G., Son, M. H., Yoon, Y. K., Kim, J. Y., Kim, M. J., Sohn, J. W., Kim, M. J. & Park, D. W. (2010). Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program. J Korean Med Sci 25, 999–1004.
5. CLSI (2012). Performance Standards for Antimicrobial Susceptibility Testing, 20th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
6. De Pascale, G., Pompucci, A., Maviglia, R., Spanu, T., Bello, G., Mangiola, A. & Scoppettuolo, G. (2010). Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin. Minerva Anestesiol 76, 957–960.
7. Gordon, N. C., Png, K. & Wareham, D. W. (2010). Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 54, 5316–5322.
8. Gunderson, B. W., Ibrahim, K. H., Hovde, L. B., Fromm, T. L., Reed, M. D. & Rotschafer, J. C. (2003). Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 47, 905–909.
9. Hall, M. J., Middleton, R. F. & Westmacott, D. (1983). The fractional inhibitory concentration (FIC) index as a measure of synergy. J Antimicrob Chemother 11, 427–433.
10. Jung, J. Y., Park, M. S., Kim, S. E., Park, B. H., Son, J. Y., Kim, E. Y., Lim, J. E., Lee, S. K., Lee, S. H. & other authors (2010). Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 10, 228.
11. Kim, Y. J., Kim, S. I., Kim, Y. R., Hong, K. W., Wie, S. H., Park, Y. J., Jeong, H. & Kang, M. W. (2012). Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection. Epidemiol Infect 140, 137–145.
12. Kiratisin, P., Apisarnthanarak, A. & Kaewdaeng, S. (2010). Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrugresistant and extensively drug-resistant isolates. Int J Antimicrob Agents 36, 243–246.
13. Kofteridis, D. P., Alexopoulou, C., Valachis, A., Maraki, S., Dimopoulou, D., Georgopoulos, D. & Samonis, G. (2010). Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case–control study. Clin Infect Dis 51, 1238–1244.
14. Kroeger, L. A., Hovde, L. B., Mitropoulos, I. F., Schafer, J. & Rotschafer, J. C. (2007). Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 51, 3431–3433.
15. Kruse, A. Y., Thieu Chuong, H., Phuong, C. N., Duc, T., Graff Stensballe, L., Prag, J., Kurtzhals, J., Greisen, G. & Pedersen, F. K. (2013). Neonatal bloodstream infections in a pediatric hospital in Vietnam: a cohort study. J Trop Pediatr 59, 483–488.
16. Lim, S. K., Lee, S. O., Choi, S. H., Choi, J. P., Kim, S. H., Jeong, J. Y., Choi, S. H., Woo, J. H. & Kim, Y. S. (2011a). The outcomes of using colistin for treating multidrug resistant Acinetobacter species bloodstream infections. J Korean Med Sci 26, 325–331.
17. Lim, T. P., Tan, T. Y., Lee, W., Sasikala, S., Tan, T. T., Hsu, L. Y. & Kwa, A. L. (2011b). In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore. PLoS One 6, e18485.
18. Lin, C. C., Liu, T. C., Kuo, C. F., Liu, C. P. & Lee, C. M. (2010). Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan. J Microbiol Immunol Infect 43, 323–331.
19. López-Rojas, R., Domınguez-Herrera, J., McConnell, M. J., Docobo- Perez, F., Smani, Y., Fernandez-Reyes, M., Rivas, L. & Pachon, J. (2011). Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 203, 545–548.
20. McGrath, E. J., Chopra, T., Abdel-Haq, N., Preney, K., Koo, W., Asmar, B. I. & Kaye, K. S. (2011). An outbreak of carbapenemresistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol 32, 34–41.
21. Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St Michael, F. & other authors (2010). Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 54, 4971–4977.
22. Moffatt, J. H., Harper, M., Adler, B., Nation, R. L., Li, J. & Boyce, J. D. (2011). Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob Agents Chemother 55, 3022–3024.
23. Nakwan, N., Wannaro, J., Thongmak, T., Pornladnum, P., Saksawad, R., Nakwan, N. & Chokephaibulkit, K. (2011). Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol 46, 60–66.
24. Nhu, N. T., Lan, N. P., Campbell, J. I., Parry, C. M., Thompson, C., Tuyen, H. T., Hoang, N. V., Tam, P. T., Le, V. M. & other authors (2014). Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. J Med Microbiol 63, 1386–1394.
25. Park, Y. K., Jung, S. I., Park, K. H., Cheong, H. S., Peck, K. R., Song, J. H. & Ko, K. S. (2009). Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn Microbiol Infect Dis 64, 43–51.
26. Paul, M., Benuri-Silbiger, I., Soares-Weiser, K. & Leibovici, L. (2004). b-Lactam monotherapy versus b-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328, 668.
27. Peleg, A. Y., Seifert, H. & Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21, 538–582.
28. Petersen, P. J., Labthavikul, P., Jones, C. H. & Bradford, P. A. (2006). In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and timekill kinetic analysis. J Antimicrob Chemother 57, 573–576.
29. Petrosillo, N., Ioannidou, E. & Falagas, M. E. (2008). Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect 14, 816–827.
30. Pourcel, C., Minandri, F., Hauck, Y., D’Arezzo, S., Imperi, F., Vergnaud, G. & Visca, P. (2011). Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J Clin Microbiol 49, 539–548.
31. Rodriguez, C. H., Bombicino, K., Granados, G., Nastro, M., Vay, C. & Famiglietti, A. (2009). Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin. Diagn Microbiol Infect Dis 65, 188–191.
32. Schultsz, C., Bootsma, M. C., Loan, H. T., Nga, T. T., Thao, T. P., Thuy, T. T., Campbell, J., Vien, M., Hoa, N. T. & other authors (2013). Effects of infection control measures on acquisition of five antimicrobial drug-resistant microorganisms in a tetanus intensive care unit in Vietnam. Intensive Care Med 39, 661–671.
33. Sheng, W. H., Wang, J. T., Li, S. Y., Lin, Y. C., Cheng, A., Chen, Y. C. & Chang, S. C. (2011). Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU. Diagn Microbiol Infect Dis 70, 380–386.
34. Song, J. Y., Cheong, H. J., Choi, W. S., Heo, J. Y., Noh, J. Y. & Kim, W. J. (2011). Clinical and microbiological characterization of carbapenemresistant Acinetobacter baumannii bloodstream infections. J Med Microbiol 60, 605–611.
35. Soon, R. L., Nation, R. L., Cockram, S., Moffatt, J. H., Harper, M., Adler, B., Boyce, J. D., Larson, I. & Li, J. (2011). Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment. J Antimicrob Chemother 66, 126–133.
36. Sopirala, M. M., Mangino, J. E., Gebreyes, W. A., Biller, B., Bannerman, T., Balada-Llasat, J. M. & Pancholi, P. (2010). Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 54, 4678–4683.
37. Tada, T., Miyoshi-Akiyama, T., Kato, Y., Ohmagari, N., Takeshita, N., Hung, N. V., Phuong, D. M., Thu, T. A., Binh, N. G. & other authors (2013). Emergence of 16S rRNA methylase-producing Acinetobacter baumannii and Pseudomonas aeruginosa isolates in hospitals in Vietnam. BMC Infect Dis 13, 251.
38. Tan, T. Y., Lim, T. P., Lee, W. H., Sasikala, S., Hsu, L. Y. & Kwa, A. L. (2011). In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods. Antimicrob Agents Chemother 55, 436–438.
39. Taylor, W. R., Nguyen, K., Nguyen, D., Nguyen, H., Horby, P., Nguyen, H. L., Lien, T., Tran, G., Tran, N. & other authors (2012). The spectrum of central nervous system infections in an adult referral hospital in Hanoi, Vietnam. PLoS One 7, e42099.
40. Wareham, D. W., Gordon, N. C. & Hornsey, M. (2011). In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother 66, 1047–1051.
41. Wiegand, I., Hilpert, K. & Hancock, R. E. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3, 163–175.
42. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G. & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351–353.
43. Zhanel, G. G., Simor, A. E., Vercaigne, L., Mandell, L. & Canadian Carbapenem Discussion Group (1998). Imipenem and meropenem: comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. Can J Infect Dis 9, 215–228.
44. Zusman, O., Avni, T., Leibovici, L., Adler, A., Friberg, L., Stergiopoulou, T., Carmeli, Y. & Paul, M. (2013). Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother 57, 5104–5111.